Ignite Creation Date:
2025-12-25 @ 12:22 AM
Ignite Modification Date:
2026-02-27 @ 3:13 AM
Study NCT ID:
NCT03184558
Status:
TERMINATED
Last Update Posted:
2021-11-09
First Post:
2017-05-30
Is Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Bemcentinib (BGB324) in Combination With Pembrolizumab in Patients With TNBC
Sponsor:
BerGenBio ASA
Organization:
Organization Data
Organization:
Class:
INDUSTRY
Study ID:
BGBC007
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None
Collaborators
Collaborators
| Name | Class | View |
|---|---|---|
| None | INDUSTRY | View |